Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 ...

A stronger, faster indigenous torpedo will help replace aging weapons and ensure the Indian Navy remains ready for future ...

Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson’s Disease and Movement Disorders® 2025·     Details of the Phase 3 ...

SOL-1 superiority trial continues to demonstrate outstanding patient retention and protocol adherence, with no new or unexpected safety signals ...

Ab Science (($ABSCF)) announced an update on their ongoing clinical study. Ab Science is spearheading a pivotal Phase 3 clinical trial titled ‘A ...

SpaceX is ramping up testing of its second launch pad at Starbase, conducting multiple checkouts of the water deluge system ...

Press Release Nicox's NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Additional pre-planned analysis of the NCX 470 Denali trial ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

AusBiotech welcomes the Albanese Government's announcement of a $13.6 million investment to progress national health and medical research reforms and ...

Renowned psychiatric nurse Ann Burgess, a former FBI consultant, describes her work as an expert witness for sexual assault ...

Tonix Pharmaceuticals (TNXP) announced plans to progress its TNX-2900 program for the treatment of Prader-Willi syndrome into a Phase 2 clinical ...